Studies in humans have shown that a genetic variant at the FABP4 locus reduced the risk for atherosclerosis, diabetes and coronary heart disease [16, 17], and reduced FABP4 expression in adipose tissue was related to lower risk for CAD and DM [16]. This evidence concerns the gene FABP4 and atherosclerosis.